Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Refractory Partial Onset Seizures in Pediatric Patients
NCT00175890Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 3, randomised, double-blind trial in focal onset seizure comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Responder Rate for total partial onset seizures at 48 hours. Started Oct 2004; status: completed.
02
Drugs
levetiracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00175890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175890.